Itron Inc. (NASDAQ:ITRI) Director Jon E. Eliassen sold 1,000 shares of the firm’s stock in a transaction on Thursday, October 6th. The stock was sold at an average price of $56.98, for a total transaction of $56,980.00. Following the transaction, the director now directly owns 16,492 shares in the company, valued at $939,714.16. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink.
Shares of Itron Inc. (NASDAQ:ITRI) opened at 56.31 on Friday. The company has a 50 day moving average of $52.99 and a 200 day moving average of $45.30. Itron Inc. has a 52 week low of $29.02 and a 52 week high of $57.25. The firm has a market cap of $2.15 billion, a PE ratio of 42.09 and a beta of 1.44.
Itron (NASDAQ:ITRI) last posted its quarterly earnings results on Thursday, September 1st. The company reported $0.65 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.43 by $0.22. The firm had revenue of $513.02 million for the quarter. Itron had a net margin of 2.62% and a return on equity of 10.94%. The company’s revenue was up 9.0% on a year-over-year basis. During the same period in the prior year, the company earned ($0.39) earnings per share. On average, equities research analysts anticipate that Itron Inc. will post $2.37 EPS for the current fiscal year.
A number of hedge funds have recently bought and sold shares of the stock. BlackRock Institutional Trust Company N.A. boosted its stake in Itron by 6.0% in the first quarter. BlackRock Institutional Trust Company N.A. now owns 1,036,667 shares of the company’s stock valued at $43,250,000 after buying an additional 58,844 shares in the last quarter. Scopia Capital Management LP boosted its stake in Itron by 26.6% in the first quarter. Scopia Capital Management LP now owns 4,475,083 shares of the company’s stock valued at $186,700,000 after buying an additional 940,900 shares in the last quarter. Renaissance Technologies LLC raised its stake in Itron by 55.3% in the first quarter. Renaissance Technologies LLC now owns 619,361 shares of the company’s stock valued at $25,840,000 after buying an additional 220,461 shares during the last quarter. Prudential Financial Inc. raised its stake in Itron by 1.7% in the first quarter. Prudential Financial Inc. now owns 94,901 shares of the company’s stock valued at $3,959,000 after buying an additional 1,570 shares during the last quarter. Finally, Capstone Asset Management Co. raised its stake in Itron by 2.2% in the second quarter. Capstone Asset Management Co. now owns 11,586 shares of the company’s stock valued at $499,000 after buying an additional 250 shares during the last quarter. 96.92% of the stock is currently owned by hedge funds and other institutional investors.
ITRI has been the topic of several research reports. Robert W. Baird reissued an “outperform” rating and set a $47.00 price objective on shares of Itron in a research report on Saturday, August 13th. TheStreet raised shares of Itron from a “hold” rating to a “buy” rating in a research report on Monday, August 29th. Canaccord Genuity reissued a “buy” rating and set a $61.00 price objective (up from $57.00) on shares of Itron in a research report on Monday, October 3rd. Zacks Investment Research upgraded shares of Itron from a “hold” rating to a “strong-buy” rating and set a $62.00 target price for the company in a research note on Friday, September 9th. Finally, Cowen and Company restated a “market perform” rating and issued a $50.00 target price (up previously from $45.00) on shares of Itron in a research note on Sunday, September 4th. One research analyst has rated the stock with a hold rating, six have assigned a buy rating and one has assigned a strong buy rating to the stock. The company currently has a consensus rating of “Buy” and an average target price of $54.71.
Itron Company Profile